The effect of the 5-HT4 agonist, Prucalopride, on a functional magnetic resonance imaging faces task in the healthy human brain
Depression is a common and often recurrent illness with significant negative impact on a global scale. Current antidepressants are ineffective for up to one third of people with depression, many of whom experience persistent symptomatology. 5-HT4 receptor agonists show promise in both animal models...
Main Authors: | , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2022
|